Poland· PL-100016512

Cytotec

A misoprostol product containing misoprostolum, registered in Poland by Pfizer Europe MA EEIG. The same ATC class is registered in 11 of our 19 countries.

ATC A02BB01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedCytotecATCA02BB01REGISTER NO.PL-100016512PACKS LISTED2CHECKEDSeptember 27, 2026

Where it is registered

Misoprostol is registered in 11 of 19 countries.

Countries holding a registration under ATC A02BB01 (misoprostol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 6 of them publish a price we can compare per daily dose

Misoprostol · ATC A02BB01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of misoprostol costs, country by country.

Normalised to the WHO defined daily dose (0.8 mg), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Misoprostol · price per daily dose (0.8 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$3.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

URPL (Poland)
Active substance
Misoprostolum
Manufacturer
Pfizer Europe MA EEIG
Country
Poland (PL)
ATC code
A02BB01
ATC class
Misoprostol
Defined daily dose
0.8 mg, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909990271627
  • gtin
    05909990271610

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

246 interactions on record for misoprostol.

Graded by severity as the source publishes them — 10 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Misoprostol · interactions on record

246 records

  • 10 moderate
  • 6 minor
  • 229 info

Most severe, free to view

  • Magnesium carbonateA02AA01moderate
  • Magnesium oxideA02AA02moderate
  • Magnesium hydroxideA02AA04moderate
  • Kombinationen von AluminiumsalzenA02AB10moderate

1 more interaction with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Misoprostol in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All misoprostol products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

  • Austria · Angusta®, Cyprostol
  • Belgium · Angusta, Cytotec
  • Bulgaria · Ангуста, Топогин
  • Cyprus · Angusta, Misoone
  • Czechia · Angusta, Mispregnol
  • Germany · Angusta, Misoone
  • Denmark · Angusta, Cytotec
  • Estonia · Angusta, Gyxiny
  • Spain · Angusta, Cytotec
  • Finland · Angusta, Cytotec
  • France · Angusta, Gymiso
  • United Kingdom (Northern Ireland) · Angusta, Cytotec
  • Greece · Angusta, Cytotec
  • Croatia · Angusta, Mispregnol
  • Hungary · Angusta
  • Ireland · Angusta, Cytotec
  • Iceland · Angusta, Cytotec
  • Italy · Angusta, Cytotec
  • Lithuania · Gyxiny, Misoone
  • Luxembourg · Angusta, Cytotec
  • Latvia · Angusta, Gyxiny
  • Malta · Angusta
  • Netherlands · Angusta, Cytotec
  • Norway · Angusta, Cytotec
  • Portugal · Angusta, Cytotec
  • Romania · Angusta, Topogyne
  • Sweden · Angusta, Cytotec
  • Slovenia · Angusta, Topogyne
  • Slovakia · Angusta

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/8161dfbc-0629-4b0b-b694-2162aba9b30a
GET /v1/drugs/8161dfbc-0629-4b0b-b694-2162aba9b30a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "200 mcg",
  "packaging": "05909990271627 ¦ Rp ¦ 2820\n50 tabl.\n05909990271610 ¦ Rp ¦ 14023\n30 tabl.",
  "substance": "Misoprostolum 200 mg",
  "common_name": "Misoprostolum",
  "pl_product_id": "100016512",
  "pozwolenie_nr": "02716",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about misoprostol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.